1. Home
  2. SID vs ADPT Comparison

SID vs ADPT Comparison

Compare SID & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Companhia Siderurgica Nacional S.A.

SID

Companhia Siderurgica Nacional S.A.

HOLD

Current Price

$1.86

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$15.91

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SID
ADPT
Founded
1941
2009
Country
Brazil
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.5B
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
SID
ADPT
Price
$1.86
$15.91
Analyst Decision
Strong Sell
Strong Buy
Analyst Count
1
10
Target Price
$1.40
$16.60
AVG Volume (30 Days)
3.0M
2.4M
Earning Date
11-04-2025
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,522,708,358.00
$252,754,000.00
Revenue This Year
$4.93
$50.81
Revenue Next Year
N/A
$1.17
P/E Ratio
N/A
N/A
Revenue Growth
4.02
42.57
52 Week Low
$1.24
$5.98
52 Week High
$1.88
$20.76

Technical Indicators

Market Signals
Indicator
SID
ADPT
Relative Strength Index (RSI) 63.56 46.26
Support Level $1.60 $15.31
Resistance Level $1.88 $17.33
Average True Range (ATR) 0.06 0.75
MACD 0.02 -0.03
Stochastic Oscillator 88.33 31.05

Price Performance

Historical Comparison
SID
ADPT

About SID Companhia Siderurgica Nacional S.A.

Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations in railways and port terminals. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: